Clinical Trial Update: Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial update for S-488410 in non-small cell lung cancer is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• S-488410

Snippet

Sponsor: Shiga University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN